CLRB Message Board Post 9182650 | Cellectar Biosciences...
home / stock / clrb / clrb message board
COOPER123
(investorshub)
Posted on: Dec/12/2022 05:44:16
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170669409
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Source:Edgar (US
News, Short Squeeze, Breakout and More Instantly...
Cellectar Biosciences Inc. Company Name:
CLRB Stock Symbol:
Market:
0.0% G/L:
$0.299 Last:
226,267 Volume:
$0.2832 Open:
$0.299 Close:
Cellectar Biosciences Inc. Website:
-
Achieves alignment with U.S. Food and Drug Administration (FDA) on regulatory path for potential accelerated approval of iopofosine I 131 as a treatment for Waldenström macroglobulinemia (WM) Evaluating timing for Phase 1 solid tumor studies; Auger-emitting radioconjugate prepared fo...
-
Team Inc. (TISI) is expected to report for quarter end 2024-12-31 Chesswood Group Limited (CHWWQ) is expected to report for Q4 2024 J. W. Mays Inc. (MAYS) is expected to report for Q2 2025 Allakos Inc. (ALLK) is expected to report $-0.17 for Q4 2024 Aurora Mobile Limited (JG) is e...
-
FLORHAM PARK, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that members of its management team ...